Agustin Argenal
Interventional Cardiology · Concord, CANPI 1629045372
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 88 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $752 and has fallen 79.1% since, to $157 in 2025. That places this record below the midpoint for interventional cardiology clinicians in CA, where the typical reported total is $8,581.
Across 88 payments — averaging $20.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amarin Pharma, Inc.$367
- Kowa Pharmaceuticals America, Inc.$300
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$275
- Philips North America LLC$269
- Johnson & Johnson$85
- Abiomed$75
- plus $423 from 12 others
What the payments were for
- Food & beverage$1,75898%
- Education$352%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amarin Pharma, Inc. | 25 | $367 |
| Kowa Pharmaceuticals America, Inc. | 13 | $300 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 14 | $275 |
| Philips North America LLC | 10 | $269 |
| Johnson & Johnson | 6 | $85 |
| Abiomed | 1 | $75 |
| Novartis | 3 | $54 |
| Pfizer | 2 | $49 |
| Biotronik Inc. | 1 | $46 |
| Amgen | 2 | $45 |
| Astellas Pharma US Inc | 2 | $40 |
| Abbott | 2 | $39 |
| Boston Scientific | 2 | $38 |
| Shockwave Medical, Inc | 1 | $33 |
| Gilead | 1 | $25 |
| Impulse Dynamics (USA) Inc. | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| AstraZeneca | 1 | $14 |
How this compares
$1,793 in reported general payments places this provider in the 20th percentile of 585 interventional cardiology providers in California.
Other interventional cardiology in Concord
- Matthew Pricela Jolla$2.3M
- Frederick St GoarMountain View$2.2M
- Saibal KarThousand Oaks$1.1M
- Rahul SharmaStanford$1M
- Puneet KhannaRancho Mirage$1M
- Dennis SheehanRedwood City$900K
- Suhail DohadBeverly Hills$802K
- Curtiss Stinisla Jolla$759K
- Christian SpiesBurlingame$719K
- Evan ZahnLos Angeles$632K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.